7HD.F NEUCA S.A.

Healthcare Medical Distribution Frankfurt Exchange
149.60 EUR
Close of Nov 11, 2026
143.95 194.59
Market cap
EUR 677M
P/E
14.9x
P/B
2.68x
ROE
19.5%
Dividend yield
2.73%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7HD.F undervalued?

Graham number
Price149.60
Graham value112.16
Premium33.4%

7HD.F trades 33.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NEUCA S.A. fundamental analysis

No fundamental analysis for NEUCA S.A. yet.

NEUCA S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NEUCA S.A.

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, …

Full company profile